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Abstract
Background: Studies of associations between plasma GSH-Px activity and cardiovascular risk factors have been done in
humans, and contradictory results have been reported. The aim of our study was to assess the association between the
scavenger antioxidant enzyme glutathione peroxidase (GSH-Px) activity in plasma and the presence of novel and classical
cardiovascular risk factors in elderly patients.
Methods: We performed a cross-sectional study with baseline data from a subsample of the PREDIMED (PREvencio´n con
DIeta MEDiterra´nea) study in Spain. Participants were 1,060 asymptomatic subjects at high risk for cardiovascular disease
(CVD), aged 55 to 80, selected from 8 primary health care centers (PHCCs). We assessed classical CVD risk factors, plasma
oxidized low-density lipoproteins (ox-LDL), and glutathione peroxidase (GSH-Px) using multilevel statistical procedures.
Results: Mean GSH-Px value was 612 U/L (SE: 12 U/L), with variation between PHCCs ranging from 549 to 674 U/L
(Variance = 1013.5; P,0.001). Between-participants variability within a PHCC accounted for 89% of the total variation. Both
glucose and oxidized LDL were positively associated with GSH-Px activity after adjustment for possible confounder variables
(P = 0.03 and P = 0.01, respectively).
Conclusion: In a population at high cardiovascular risk, a positive linear association was observed between plasma GSH-Px
activity and both glucose and ox-LDL levels. The high GSH-Px activity observed when an oxidative stress situation occurred,
such as hyperglycemia and lipid oxidative damage, could be interpreted as a healthy defensive response against oxidative
injury in our cardiovascular risk population.
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Introduction
Coronary heart disease (CHD) is a major cause of morbidity
and mortality in the developed world [1]. Atherosclerosis,
characterized by the accumulation of cholesterol deposits in large
and medium-sized arteries, is the most common pathologic process
underlying cardiovascular disease and is often clinically manifested
as coronary, cerebrovascular, and/or peripheral arterial disease
[2]. An imbalance between antioxidant and oxidant-generating
system that leads to oxidative stress has been proposed in the
pathogenesis of atherosclerosis [2]. In particular, the oxidation of
low density lipoproteins (LDL) by free radicals plays a central role
in the formation, progression, and rupture of atherosclerotic
plaques [2].
Mammalian cells are, however, protected from free radicals by
a wide range of antioxidants such as the scavenger antioxidant
enzymes [3]. Glutathione peroxidase is the general name for a
family of multiple isozymes that catalyze the reduction of H2O2 or
organic hydroperoxides to water or the corresponding alcohols
using reduced glutathione (GSH) as an electron donor. In
mammals, 8 glutathione peroxidases (GPx1–GPx8) have been
identified to date, including both selenium-containing GPxs
(GPx1–4 and 6) and their non-selenium congeners (GPx5, 7 and
8) [4].
Oxidative stress elicits an induction of antioxidant enzymes, as
reported in a recent systematic review [5]. However, most studies
were done in animal models; studies that have analyzed this
association in humans have reported conflicting results [6–15].
The aim of the present study was to assess the association
between the scavenger antioxidant enzyme glutathione peroxidase
(GSH-Px) activity in plasma and novel and classical cardiovascular
risk factors in elderly individuals at high risk for cardiovascular
disease.
Methods
Study design
A cross-sectional study with baseline data from a subsample of
the PREDIMED (PREvencio´n con DIeta MEDiterra´nea) study
was performed. The PREDIMED study is a large, parallel-group,
multicenter, randomized, controlled, clinical trial aimed at
assessing the effects of the traditional Mediterranean diet (TMD)
on the primary prevention of cardiovascular disease (www.
predimed.es and www.predimed.org). The PREDIMED detailed
protocol of the study has been previously published [16].
Subjects
Of the 7,447 participants aged 55 to 80 years from 8 Spanish
PHCCs who were randomized to the PREDIMED study groups,
1,069 were randomly selected a posteriori for plasma measure-
ments of glutathione peroxidase-1 activity and included in the
present study. Inclusion criteria were the presence of diabetes or at
least 3 CHD risk factors: current smoking; hypertension (systolic
blood pressure $140 mm/Hg, diastolic blood pressure $90
mm/Hg, or treatment with antihypertensive drugs); dyslipidemia
(high-density lipoprotein [HDL] cholesterol ,40 mg/dL for men
and ,50 mg/dL for women, LDL cholesterol.160 mg/dL, or
treatment with cholesterol-lowering drugs); overweight or obesity
(body mass index (BMI).25 kg/m2), or family history of
premature CHD. Exclusion criteria were history of cardiovascular
disease, any severe chronic illness, drug or alcohol addiction,
history of allergy or intolerance to olive oil or nuts, or low
predicted likelihood of changing dietary habits according to the
stages of change model. Individual eligibility was based on a
screening visit by the primary care physician.
Baseline assessments
The baseline examination included the administration of 3 types
of questionnaire: 1) a validated food frequency questionnaire [17]
and an assessment of the degree of adherence to the TMD,
assigning a value of 0 or 1 to each of 14 questionnaire items [18],
with energy and nutrient intake calculated from Spanish food
composition tables [19]; 2) the Minnesota Leisure Time Physical
Activity Questionnaire, which has been validated for its use in
Spanish men and women [20,21]; and 3) a 47-item general
questionnaire assessing life-style, health conditions, smoking
habits, sociodemographic variables, history of illness, and medi-
cation use. Weight and height were measured with calibrated
scales and a wall-mounted stadiometer, respectively. Waist
circumference was measured midway between the lowest rib and
the iliac crest using an anthropometric tape. Trained personnel
measured blood pressure in triplicate with a validated semi-
automatic sphygmomanometer (Omron HEM-705CP, The Neth-
erlands) with the patient in a seated position after a 5-minute rest.
Laboratory analysis
Biological samples were obtained after an overnight fast, coded,
shipped to central laboratories, and frozen at 280uC until the
assay. Plasma glucose and lipid analyses were performed in a
PENTRA-400 autoanalyzer (ABX-Horiba Diagnostics, Montpel-
lier, France). Soluble HDL cholesterol was measured by an
accelerator selective detergent method (ABX-Horiba Diagnostics,
Montpellier, France) and LDL cholesterol was calculated by the
Friedewald equation whenever triglycerides were ,3.4 mmol/L.
Quality control was performed with UNITY External Quality
Assessment (BIO-RAD, Hercules, CA, USA). Circulating oxidized
LDL (ox-LDL) plasma levels were measured by a commercial
enzyme-linked immunoabsorbent assay (Mercodia AB, Uppsala,
Sweden). Intra- and inter-assay coefficients of variation were 2.8%
and 7.3%, respectively. Plasma GSH-Px activity (GSH-Px; EC
1.11.1.9) was measured by a Paglia and Valentine [22] modifi-
cation method using cumene hydroperoxide (Ransel RS 505,
Randox Laboratories, Crumlin, UK) as a glutathione oxidant.
Intra- and inter-run imprecision were 3.6% and 5.43%, respec-
tively.
Statistical analyses
Participants were divided into quintiles of plasma GSH-Px
concentration based on the sample distribution. We ensured that
the result was not due to multiple comparisons, so we conducted
the Holm adjustment [23,24]. This method is just as simple and
generally applicable as the Bonferroni method, but much more
powerful [25,26].
We applied multilevel statistical procedures [27] to investigate
both the association between individual cardiovascular risk factors
and GSH-Px and to what extent differences between PHCTs may
account for any variation in the outcomes. We modeled
individuals (level-1 units) as nested within 8 PHCTs (level-2 units).
We modeled the continuous outcome (GSH-Px) using the
multilevel linear regression to allow for within-center correlation,
applying the Full Maximum likelihood method of estimation.
Initially, we examined whether there was a variation between
Spanish PHCTs in GSH-Px activity by fitting an unconditional
model with no predictors at any level, only the intercept and
random errors at the individual and PHCT levels. The second
model estimated the effect of individual (level 1) covariates on the
outcome and whether these effects varied by PHCT (i.e., we
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allowed for level-2 random effects). We confirmed the appropri-
ateness of modeling continuous variables as linear (fractional
polynomials method).
All statistical tests were 2-sided at the 5% significance level.
Analyses were carried out using the HLM for Windows multilevel
package, version 10.1, Stata/SE version 9.1 (Stata Corp.).
Research ethics
The study followed the principals contained in the Helsinki
Declaration and successive revisions and the standards of good
clinical practice. The protocol was approved by the Committee on
Clinical Research Ethics (CEIC) of the Institut d9Investigacio´ en
Atencio´ Prima`ria (IDIAP) Jordi Gol, and participants signed an
informed consent. Data confidentiality was guaranteed according
to the pertinent laws of Spain (Ley Orga´nica de Protection de
Datos de Cara´cter Personal, 15/1999, December 1).
Results
Of the 1,060 included participants, 577 (54.4%) were female.
The mean age was 66.7 (SD: 8.0) years. GSH-Px activity showed a
normal distribution. Plasma glucose and ox-LDL levels increased
across GSH-Px quintiles (P,0.05). (Table 1).
Table 2 shows the results of both the unconditional and the
adjusted model for the association between GSH-Px and
cardiovascular risk factors. From the results of the unconditional
model, the GSH-Px mean value was 612 U/L (SE: 12 U/L), with
a significant variation between PHCCs, ranging from 549 to 674
U/L (Variance = 1013.5; P,0.001). The variation in the mean
level of GSH-Px was 15 times greater within PHCCs than between
PHCCs (Variance = 15266.6; P,0.001). Thus, 93.8% of the
variability in GSH-Px activity was between participants within
centers rather than between PHCCs. The adjusted model
(Table 2) showed a reduction in the mean GSH-Px value to 577
U/L (SE: 50 U/L), with a range of variation between PHCCs
from 499 to 656 U/L. Results of this model showed that glucose
and oxidized LDL were significantly positively associated with
GSH-Px activity (P,0.05).
Discussion
This study assessed the association between GSH-Px activity
and classical and novel cardiovascular risk factors in an elderly
population with high cardiovascular risk. We identified a positive
association between plasma GSH-Px activity and glucose and ox-
LDL levels. The associations were moderately strong and linear,
Table 1. Participant characteristics by quintiles of serum glutathione peroxidase activity (U/L).
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
P value for
trend*
,507 507567 567–618 618–685 .685
(n = 213) (n = 219) (n = 212) (n = 215) (n = 210)
Age (years) 67.169.2 66.268.8 67.567.9 66.666.7 66.367.1 1.000
Sex (female), n (%) 122 (57.1) 116 (52.5) 123 (58.6) 113 (53.3) 107 (50.7) 1.000
Current smokers, n (%) 46 (21.8) 48 (22.4) 46 (22.1) 37 (17.5) 30 (14.5) 1.000
Diabetes, n (%) 94 (44.3) 99 (45.6) 96 (45.7) 112 (52.8) 118 (56.5) 0.076
Hypertension, n (%) 170 (79.7) 177 (81.1) 172 (82.2) 180 (84.8) 160 (76.8) 1.000
Systolic blood pressure (mmHg) 156661 159661 153620 158654 157662 1.000
Diastolic blood pressure (mmHg) 88663 89663 84611 89656 89664 1.000
Medication use, n (%)
Antihypertensive agents 153 (73.2) 154 (74.0) 151 (73.7) 156 (75.7) 139 (67.8) 1.000
Lipid-lowering agents 78 (37.3) 96 (46.2) 89 (43.4) 84 (40.8) 95 (46.6) 1.000
Insulin 13 (6.2) 14 (6.8) 7 (3.4) 21 (10.3) 17 (8.3) 1.000
Oral hypoglycemic agents 57 (27.1) 55 (26.4) 55 (26.8) 68 (33.2) 71 (34.6) 0.435
Aspirin or other antiplatelet agents 52 (24.8) 40 (19.1) 43 (20.7) 63 (30.4) 49 (19.8) 1.000
Waist circumference (cm) 107.6688.8 104.3662.9 101.6653.7 97.8610.3 98.3611.1 0.468
EEPA leisure time (kcal/day) 2246181 2376195 2776250 2736253 2676240 0.216
Glucose (mg/dL) 117634 118635 119634 125640 126639 0.042
Cholesterol (mg/dL)
Total 203630 205.8632.3 209.2631.2 210.8635.6 207.5635.0 0.480
High density lipoprotein (HDL) 50.4610.5 50.7610.0 53.2610.0 52.6610.7 52.3610.2 0.288
Low density lipoprotein (LDL) 126626 128627 131626 133628 130629 0.216
LDL/HDL cholesterol ratio 2.5260.62 2.5660.59 2.5160.58 2.5960.61 2.5260.58 1.000
Triglycerides (mg/dL) 132663 133662 124653 124655 122665 0.435
Oxidized LDL (U/L) 70624 74626 74626 76626 78627 0.042
Abbreviations: EEPA, daily energy expenditure in leisure-time physical activity. Data are shown as mean 6SD, median (interquartile range), or percentage.
* P value for trend adjusted for multiple testing using Holm correction [24]. One-factor analysis of variance, nonparametric Kruskal Wallis test, and chi-square test were
used as appropriate.
doi:10.1371/journal.pone.0105881.t001
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and persisted after adjustment for age, sex, and other possible
confounders.
Although several studies have reported an association between
cardiovascular risk factors and GSH-Px, they included small
sample sizes and report contradictory results [6–15]. Furthermore,
the results shown were either unadjusted [7,8,10–13] or adjusted
only by age or sex [6,9,14,15]. Whereas several studies examined
the association between GSH-Px activity and diabetes and
reported lower serum GSH-Px activity in patients with type 2
diabetes than in non-diabetic participants [6,7,14], other studies
found increased GSH-Px activity in diabetic patients, compared to
control group [9,15]. Finally, one study found no significant
difference in GSH-Px activity between three study groups (diabetic
patients with and without hypertension and pre-diabetic patients)
[8]. In other results, two of these studies reported a positive
relationship between BMI and the antioxidant activity of GSH-Px
[9,12], another study found significantly lower erythrocyte GSH-
Px activity in obese women compared to normal weight women
[10], and one study found no significant differences in GSH-Px
activity between patients with essential hypertension and age- and
sex-matched healthy controls older than 65 years [13].
The biological oxidative effects of reactive oxygen species (ROS)
on lipids, DNA, and proteins are controlled by a wide spectrum of
exogenous antioxidant mechanisms, such as vitamins and phenolic
compounds in diet, and also by endogenous antioxidants such as
the scavenger enzymes, among them GSH-Px [28]. Hyperglyce-
mia is a situation in which ROS are generated [29]. In turn, ROS
production induces GSH-Px generation at DNA transcriptional
level [30]. Thus, high GSH-Px activity may result from a
preservation of the enzyme by a high antioxidant status (with
low generation of ROS) or from increased GSH-Px production
stimulated by ROS. Therefore, GSH-Px activity may serve as an
indicator of the balance between oxidative status and the
bioscavenging of ROS by antioxidants. In the present study we
measured the in vivo ox-LDL as a marker of oxidative stress in
order to examine the relationship between oxidative stress or
damage and GSH-Px antioxidant enzyme activity. In our
cardiovascular risk population, mean (6 standard deviation) ox-
LDL values (74626 U/L) were higher than those obtained in a
healthy population (49622 U/L) using the same method and
antibodies as in our study [31]. The positive linear relationship
obtained between GSH-Px and both glucose and ox-LDL in our
population would be compatible with enhanced production of
GSH-Px when oxidative status is increased.
Induction of GSH-Px activity has been proposed as the
mechanism by which preconditioning exerts protection in
myocardial infarction [30]. In addition, overexpression of intra-
cellular GSH-Px in transgenic animal models has shown to
prevent postischemic free radical injury [32]. Cardiovascular risk
factors present in our population, such as hypertension, diabetes,
hyperlipidemia, and obesity, have been previously linked to
oxidative stress and oxidative damage [33,34]. In this population,
the fact that a high GSH-Px activity is observed when an oxidative
stress situation occurs, such as hyperglycemia and lipid oxidative
damage, could be interpreted as a healthy defensive response
against the oxidative injury.
Table 2. Fixed and random parameters from a multilevel linear regression model of GSH-Px activity.
Adjusted Beta coefficienta Standard Error P value
UNCONDITIONAL MODEL
Fixed parameters
Intercept 612 12.43 ,0.001
Random parametersb Estimate P
PHCC-level Variance 1013.51 ,0.001
Individual-level Variance 15266.61
ADJUSTED MODEL
Fixed parameters
Intercept 577 50.07 ,0.001
Glucose (mg/dl) 0.31 0.13 0.021
Sex (female vs. male) 29.27 10.34 0.370
Age (years) 20.53 0.54 0.330
EEPA leisure time (kcal/day) 0.02 0.02 0.251
Smoking (current smoking vs. nonsmoker) 219.50 11.88 0.101
Insulin (treatment vs. no treatment) 24.66 18.17 0.175
Oral hypoglycemic agents (use vs. no use) 10.36 11.58 0.371
Oxidized LDL (mg/dL) 0.47 0.20 0.017
LDL/HDL cholesterol 2.23 8.23 0.786
Waist circumference (cm) 20.10 0.08 0.224
Random parametersb Estimate P
PHCC-level Variance 1600.17 ,0.001
Individual-level Variance 14640.03
Abbreviations: EEPA, daily energy expenditure in leisure-time physical activity. PHCC, primary health care center.
aAdjusted b, regression coefficient of the association between each variable in the model and GSH-Px activity, controlling for the other variables in the model.
bRandom parameters are multilevel measures of outcome variation. PHCC was considered as random.
doi:10.1371/journal.pone.0105881.t002
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The potential of selenoproteins such as selenium-containing
GPxs (GPx1–4 and 6) to protect against oxidative stress led to the
expectation that selenium would also be protective against type 2
diabetes and other cardiovascular risk factors. However, more
recent findings form observational studies and randomized clinical
trials have raised concerns that high selenium exposure may lead
to type 2 diabetes, insulin resistance, or hyperlipidemia [39].
Additional evidence is needed to provide new insights into the role
of selenium and of specific selenoproteins in human biology,
especially to clarify the underlying mechanisms linking selenium to
chronic disease endpoints. Further epidemiological studies and
randomized clinical trials across populations with a different
selenium status should be conducted to determine the causal effect
of selenoproteins on the development of cardiovascular risk factors
and diseases.
This study has strengths and limitations. A strength is its large
sample size, geographically widespread within Spain. In addition,
the study was carefully conducted using standardized protocols.
The multilevel methodological approach allowed us to control for
clustering within the PHCCs, thus assessing both the individual
independent factors that may influence outcomes and whether
there was variability in the plasma GSH-Px activity across
PHCCs.
One of the limitations of our study is its cross-sectional design,
which can identify associations but not causality. Moreover, cross-
sectional studies are notably subject to confounding; for this
reason, the analysis was adjusted for possible confounding factors.
A large cross-sectional study such as this one contributes to the
establishment of new hypotheses for large prospective studies and
clinical trials. The relationship between selenoproteins such as
GSH-Px and cardiovascular risk factors is undoubtedly complex.
Future studies should genotype participants and investigate the
potential interactions between genotype, selenium intake or status,
and selenoproteins. Besides, they should explore whether other
individual factors or contextual features (such as factors linked to
geographical or environmental characteristics of PHCTs) may
account for variation in the GSH-Px values.
Our study focused on an elderly population and cannot be
extrapolated to a general population. Another potential limitation
is that a survival bias could have underestimated the association
between GSH-Px activity and cardiovascular risk factors. It is
possible that subjects with diabetes, obesity, or hypertension and
low GSH-Px activity may have died or developed a cardiovascular
disease, and therefore could not be included in our study.
Moreover, we could not take into account the duration and
control of diabetes in our analyses because these data were not
available.
In conclusion, a positive linear association was observed
between plasma GSH-Px activity and glucose and ox-LDL levels
in an elderly population with high cardiovascular risk. The high
GSH-Px activity observed when an oxidative stress situation
occurs, such as hyperglycemia and lipid oxidative damage, would
be compatible with an increase in antioxidant defenses against
oxidative injury in our cardiovascular risk population. Further
epidemiological studies and randomized clinical trials are needed
to assess the impact of selenoproteins on the development of
cardiovascular risk factors and diseases and the cause-effect
relationships between hyperglycemia, oxidative status, and GSH-
Px in elderly populations at high cardiovascular risk.
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